Clinical trial

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

NCT01343745

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-02-01

PhasePHASE2

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2021-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Persistent Asthmaunresolved

Interventions

BDP/formoterolDRUG

PlaceboDRUG

Sponsors & collaborators

Chiesi Farmaceutici S.p.A.lead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01343745 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.